DALLIN KILPACK: Open Payments
NPI 1992465637 · MANTI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$104 in 6 payments from 4 companies in 2025. Trend: 2023 $390 · 2024 $97 · 2025 $104
Food & beverage: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: VRAYLAR, UBRELVY, JARDIANCE, PREVNAR 20, ZORYVE.
Industry payments across UT — which companies pay providers there.
